top of page

SCIENCE Magazine: Cancer in sub-Saharan Africa

  • Jan 3, 2020
  • 1 min read

Updated: Sep 21, 2021

Cancer in sub-Saharan Africa by Timothy Rebbeck Science Magazine Global Health


Knowledge of cancer in Africa brings needed diversity to improve health worldwide


Summary Cancer is an increasing global public health burden. This is especially the case in sub-Saharan Africa (SSA); high rates of cancer—particularly of the prostate, breast, and cervix—characterize cancer in most countries in SSA. The number of these cancers in SSA is predicted to more than double in the next 20 years (1). Both the explanations for these increasing rates and the solutions to address this cancer epidemic require SSA-specific data and approaches. The histopathologic and demographic features of these tumors differ from those in high-income countries (HICs). Basic knowledge of the epidemiology, clinical features, and molecular characteristics of cancers in SSA is needed to build prevention and treatment tools that will address the future cancer burden. The distinct distribution and determinants of cancer in SSA provide an opportunity to generate knowledge about cancer risk factors, genomics, and opportunities for prevention and treatment globally, not only in Africa.



Please contact us if you are having difficulty accessing the full PDF of this or any MADCaP publication.


Recent Posts

See All

Comments


© Copyright 2016-2022 

Dana-Farber Cancer Institute.

Use of MADCaP is subject to our terms of use and our privacy policy.

MADCaP Network
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Supported by Dana-Farber Cancer Institute

MADCaP is grant-funded by the National Cancer Institute

NCI_Stacked_COLOR.png
img-logo-2x-new.png
bottom of page